Overview
VGNT market data
Price History
VGNT price chart · 1M
- O
- 47.60
- H
- 48.68
- L
- 47.60
- C
- 48.51
- Vol
- 41,635.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $47.60
- Previous Close
- $47.37
- Day High
- $48.68
- Day Low
- $47.60
- 52 Week High
- $50.64
- 52 Week Low
- $33.88
- 7 Day Return
- +4.05%
- 30 Day Return
- +9.88%
- 90 Day Return
- +9.83%
- 1 Year Return
- +41.39%
- Daily Notional Volume
- $2M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 5.35 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $7.43 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.27 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 1.1% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 5.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $26.34 – $50.89 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $3.2B · P/S 0.29.
Company News
David Einhorn Has 7 New Stock Picks: Hedge Fund Manager Bets on Buyouts, SpinoffsBenzinga · Aug 19, 2026, 2:24 PM
Argus Research Maintains Buy on Versigent, Raises Price Target to $54Benzinga · Aug 13, 2026, 1:12 PM
Evercore ISI Group Maintains Outperform on Versigent, Raises Price Target to $65Benzinga · Aug 10, 2026, 4:42 PM
TD Cowen Maintains Buy on Versigent, Raises Price Target to $58Benzinga · Aug 5, 2026, 7:28 PM
RBC Capital Upgrades Versigent to Outperform, Raises Price Target to $52Benzinga · Aug 5, 2026, 3:19 PM
Wells Fargo Maintains Overweight on Versigent, Raises Price Target to $56Benzinga · Aug 5, 2026, 3:10 PM
Versigent shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance above estimates.Benzinga · Aug 4, 2026, 11:58 AM
8-K filing — Versigent PLC (VGNT)SEC EDGAR · Aug 4, 2026, 10:59 AM
Versigent Q2 EPS $1.92 Beats $1.35 Estimate, Sales $2.444B Beat $2.313B EstimateBenzinga · Aug 4, 2026, 10:56 AM
CORRECTION: Versigent Raises FY2026 Sales Guidance from $9.100B-$9.400B to $9.400B-$9.600B vs $9.286B EstBenzinga · Aug 4, 2026, 10:48 AM